# Rani Therapeutics Holdings, Inc.: Form 8-K, filed Jan 2, 2026

- Company: [Rani Therapeutics Holdings, Inc.](/companies/rani.md) (CIK 1856725)
- Form: 8-K
- Filed: 2026-01-02
- Accepted by EDGAR: Jan 2, 2026, 17:27 ET
- Period: 2025-12-31
- Accession: 0001193125-26-001098
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1856725/000119312526001098/d848686d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1856725/000119312526001098/

## Items reported

- Item 1.02: Termination of a material agreement
- Item 3.03: Change to security holders’ rights
- Item 5.03: Amendment to articles or bylaws
- Item 5.07: Shareholder vote results
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1856725/000119312526001098/d848686d8k.htm

Filed Jan 2, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-001098. Last ingested by Listed: Oct 24, 2026, 15:16 ET. No prices; not investment advice.